Relation between absorption half-life values of four novel sustained-release dosage forms of valproic acid in dogs and humans.
D000284:Administration, Oral; D000818:Animals; D003692:Delayed-Action Preparations; D004285:Dogs; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D014635:Valproic Acid / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D014635:Valproic Acid